International Consortium for Innovation and Quality in Pharmaceutical Development (IQ)

At a Glance
  • Status: Active Consortium
  • Year Launched: 2011
  • Initiating Organization: IQ
  • Initiator Type: Industry
  • No disease focus
  • Location: International


The International Consortium for Innovation and Quality in Pharmaceutical Development (IQ) is a technically focused organization of pharmaceutical and biotechnology companies with a mission of advancing science-based and scientifically driven standards and regulations for pharmaceutical and biotechnology products worldwide.


IQ’s vision is to be the leading science-based organization advancing innovative solutions to biomedical problems and enabling pharmaceutical companies to bring quality medicines to patients.

As a technically focused organization of pharmaceutical and biotechnology companies, IQ advances science and technology to augment the capability of member companies to bring transformational solutions that benefit patients, regulators, and the broader research and development community.

IQ provides a sustained forum for the exchange of ideas within and across technical disciplines in these industries. It leads initiatives in the areas of chemistry, manufacturing, and control; preclinical safety; drug metabolism; clinical pharmacology; quality; and the reduction, refinement, and replacement of animal testing. As part of these initiatives, which are managed by leadership groups and working groups, members lead and participate in collaborative research, industry surveys, and benchmarking exercises.

IQ partners with governmental bodies, other trade groups, and academic researchers. Through publications, scientific conferences, workshops, and roundtables, it shares the results of its work and facilitates constructive scientific exchange.

To accomplish its mission, IQ has developed a series of strategic objectives. Its strategic objectives for 2015-2017 are as follows:

Points of Contact

Please contact the IQ Secretariat at

Sponsors & Partners



Alexion Pharmaceuticals



Amgen, Inc.

Astellas Pharma US LLC

AstraZeneca Pharmaceuticals

Bayer HealthCare

Baxter HealthCare Corporation


Blueprint Medicines

Boehringer Ingelheim

Bristol-Myers Squibb

Celgene Corporation

Daiichi Sankyo

Eisai, Inc.

Eli Lilly and Company

EMD Serono

Endo Pharmaceuticals


Gilead Sciences


Incyte Corporation

Infinity Pharmaceuticals

Johnson & Johnson

Kythera Biopharmaceuticals

Merck & Co.






Otsuka Pharmaceutical Co.


Teva Pharmaceutical

Vertex, Inc.

Last Updated: 04/15/2016

The Consortia-pedia Catalogue is a living resource, and we are always adding new consortia. Provide information here about your collaboration to apply to be included in the Catalogue.

All the information contained in the Consortia-pedia was collected from publically available sources. Decisions to include or exclude a particular listing from Consortia-pedia were also made on the basis of publically available information and the criteria outlined in the FAQs. This site is intended to be an objective resource for the community, and inclusion does not constitute or imply endorsement, recommendation, or approval by FasterCures or the Milken Institute.